HZNP Share Price

Open 13.70 Change Price %
High 13.86 1 Day -0.17 -1.24
Low 13.38 1 Week 0.00 0.00
Close 13.56 1 Month -0.35 -2.52
Volume 3330328 1 Year -6.74 -33.20
52 Week High 21.98
52 Week Low 9.45
HZNP Important Levels
Resistance 2 14.00
Resistance 1 13.82
Pivot 13.60
Support 1 13.30
Support 2 13.12
NASDAQ USA Most Active Stocks
YHOO 52.58 0.00%
YHOO 52.58 0.00%
YHOO 52.58 0.00%
FNFG 10.18 -0.20%
DELL 13.86 0.22%
RFMD 16.59 -2.07%
MU 44.31 6.39%
MU 44.31 6.39%
MU 44.31 6.39%
RIMM 13.03 0.39%
More..
NASDAQ USA Top Gainers Stocks
LOCM 0.09 50.00%
SCHS 0.04 33.33%
BSDM 0.62 26.53%
SNTA 0.34 25.93%
HLIT 3.70 25.42%
OTT 2.39 25.13%
QNST 8.90 20.76%
VRTA 4.00 19.40%
SNSS 2.56 19.07%
GCFB 0.44 18.92%
More..
NASDAQ USA Top Losers Stocks
TXCC 0.01 -95.00%
GMETP 0.15 -76.92%
HCIIP 10.10 -67.52%
CRMB 0.27 -57.81%
KIOR 0.03 -57.14%
OSH 0.26 -49.02%
OSH 0.26 -49.02%
DVOX 0.05 -44.44%
PRXI 0.21 -43.24%
TRGT 0.96 -41.46%
More..

Horizon Pharma, Inc. (NASDAQ: HZNP)

HZNP Technical Analysis 1.5
As on 31st Oct 2017 HZNP Share Price closed @ 13.56 and we RECOMMEND Sell for LONG-TERM with Stoploss of 14.09 & Buy for SHORT-TERM with Stoploss of 13.20 we also expect STOCK to react on Following IMPORTANT LEVELS.
HZNP Target for November
1st Target up-side 14.47
2nd Target up-side 15.11
3rd Target up-side 15.75
1st Target down-side 12.65
2nd Target down-side 12.01
3rd Target down-side 11.37
HZNP Other Details
Segment EQ
Market Capital 138607328.00
Sector Healthcare
Industry Drugs - Generic
Offical website http://www.horizonpharma.com
HZNP Address
HZNP
520 Lake Cook Road
Suite 520
Deerfield, IL 60015
United States
Phone: 224-383-3000
Fax: 224-383-3001
HZNP Latest News
Interactive Technical Analysis Chart Horizon Pharma, Inc. ( HZNP NASDAQ USA )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on Horizon Pharma, Inc.
HZNP Business Profile
Horizon Pharma, Inc. operates as a biopharmaceutical company. It is focused on developing and commercializing medicines to target unmet therapeutic needs in arthritis, pain and inflammatory diseases.